Venetoclax in combination with chidamide and azacitidine for the treatment of relapsed/refractory B-cell acute lymphoblastic leukemia with the MLL-AF4 gene: a case report and literature review. The gene discussed is AFF1; the disease is B-cell acute lymphoblastic leukemia.